Our Program Project Grant (PPG) utilizes recent advances in chromatin biology, so-called epigenetics, to fundamentally increase our understanding of the long-lasting neural and synaptic abnormalities in the brain that underlie stimulant and opiate addiction. Our work focuses on key brain reward regions, nucleus accumbens (NAc) and areas of prefrontal cortex (PFC), which have been widely implicated in addiction. The PPG is composed of four Projects at three universities. The four PIs, Eric Nestler (Mount Sinai), Robert Malenka (Stanford), David Self (UT Southwestern), and Yasmin Hurd (Mount Sinai), are leaders in their fields who have an established history of effective collaboration and use their complementary expertise and approaches to chart a multidisciplinary course in the proposed research. Project 1 (Nestler) focuses on transcriptional and epigenetic changes induced in brain reward regions by self-administered stimulants and opiates. Project 2 (Malenka) mines those complex datasets to understand the molecular-cellular basis of neural and synaptic plasticity in brain reward neurons and how that plasticity influences circuit-level function. Projects 3 (Self) and 4 (Hurd) carry out parallel investigations into how this molecular and cellular pathology drives addiction-related behavioral abnormalities. Project 4 also validates these findings from animals in human postmortem brain tissue and thereby establishes the relevance of the basic research for human addiction. The PPG is supported by three Cores, an Administrative Core to oversee and coordinate PPG operations;an Animal and Molecular Models Core to provide animal models of addiction and the advanced tools (viral-mediated gene transfer, inducible mutations in mice, and optogenetics) to manipulate individual genes of interest or neural activity within limbic structures, and thereby provide causal evidence linking molecular-cellular-circuit plasticity to addiction-related phenomena;and a Chromatin and Gene Analysis Core to provide advanced state-of-the-art methods and bioinformatics to characterize genome-wide regulation of gene expression and chromatin modifications in addiction. This pioneering investigation of the molecular neurobiology of addiction will continue to help drive major advances in the field.

Public Health Relevance

Addiction remains one of the world's greatest public health problems, yet its pathophysiology remains incompletely understood and available treatments for addictions to various drugs of abuse are inadequately effective for most people. We believe that the most effective way of eventually developing definitive treatments and cures for addiction rests in part in a better understanding of its underlying neurobiology.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IFCN-B (40))
Program Officer
Pollock, Jonathan D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
Schools of Medicine
New York
United States
Zip Code
Monteggia, Lisa M; Heimer, Hakon; Nestler, Eric J (2018) Meeting Report: Can We Make Animal Models of Human Mental Illness? Biol Psychiatry 84:542-545
Clark, Christopher R; Maile, Makayla; Blaney, Patrick et al. (2018) Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Sci Rep 8:15327
Cates, Hannah M; Heller, Elizabeth A; Lardner, Casey K et al. (2018) Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing. Biol Psychiatry 84:167-179
Cahill, M E; Walker, D M; Gancarz, A M et al. (2018) The dendritic spine morphogenic effects of repeated cocaine use occur through the regulation of serum response factor signaling. Mol Psychiatry 23:1474-1486
Hamilton, Peter J; Burek, Dominika J; Lombroso, Sonia I et al. (2018) Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress. Neuropsychopharmacology 43:272-284
Egervari, Gabor; Kozlenkov, Alexey; Dracheva, Stella et al. (2018) Molecular windows into the human brain for psychiatric disorders. Mol Psychiatry :
de la Fuente Revenga, Mario; Ibi, Daisuke; Saunders, Justin M et al. (2018) HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice. Neuroscience 388:102-117
Anderson, Ethan M; Sun, Haosheng; Guzman, Daniel et al. (2018) Knockdown of the histone di-methyltransferase G9a in nucleus accumbens shell decreases cocaine self-administration, stress-induced reinstatement, and anxiety. Neuropsychopharmacology :
Hamilton, Peter J; Lim, Carissa J; Nestler, Eric J et al. (2018) Stereotaxic Surgery and Viral Delivery of Zinc-Finger Epigenetic Editing Tools in Rodent Brain. Methods Mol Biol 1867:229-238
Inquimbert, Perrine; Moll, Martin; Latremoliere, Alban et al. (2018) NMDA Receptor Activation Underlies the Loss of Spinal Dorsal Horn Neurons and the Transition to Persistent Pain after Peripheral Nerve Injury. Cell Rep 23:2678-2689

Showing the most recent 10 out of 312 publications